1. Home
  2. ANY vs AFMD Comparison

ANY vs AFMD Comparison

Compare ANY & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANY
  • AFMD
  • Stock Information
  • Founded
  • ANY N/A
  • AFMD 2000
  • Country
  • ANY United States
  • AFMD Germany
  • Employees
  • ANY N/A
  • AFMD N/A
  • Industry
  • ANY Finance: Consumer Services
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANY Finance
  • AFMD Health Care
  • Exchange
  • ANY Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • ANY 12.2M
  • AFMD 14.5M
  • IPO Year
  • ANY N/A
  • AFMD 2014
  • Fundamental
  • Price
  • ANY $0.48
  • AFMD $0.75
  • Analyst Decision
  • ANY Strong Buy
  • AFMD Strong Buy
  • Analyst Count
  • ANY 1
  • AFMD 5
  • Target Price
  • ANY $3.00
  • AFMD $13.50
  • AVG Volume (30 Days)
  • ANY 246.4K
  • AFMD 86.2K
  • Earning Date
  • ANY 05-12-2025
  • AFMD 04-08-2025
  • Dividend Yield
  • ANY N/A
  • AFMD N/A
  • EPS Growth
  • ANY N/A
  • AFMD N/A
  • EPS
  • ANY N/A
  • AFMD N/A
  • Revenue
  • ANY $16,608,000.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • ANY N/A
  • AFMD N/A
  • Revenue Next Year
  • ANY N/A
  • AFMD $225.65
  • P/E Ratio
  • ANY N/A
  • AFMD N/A
  • Revenue Growth
  • ANY N/A
  • AFMD N/A
  • 52 Week Low
  • ANY $0.38
  • AFMD $0.70
  • 52 Week High
  • ANY $1.90
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • ANY 35.96
  • AFMD 30.79
  • Support Level
  • ANY $0.38
  • AFMD $0.70
  • Resistance Level
  • ANY $0.46
  • AFMD $0.79
  • Average True Range (ATR)
  • ANY 0.04
  • AFMD 0.05
  • MACD
  • ANY 0.01
  • AFMD -0.01
  • Stochastic Oscillator
  • ANY 50.32
  • AFMD 20.97

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: